Context
The thyrotropin (TSH) receptor (TSH-R) autoantibody activity is clinically measured by inhibition of labeled ligand (TSH or M22) binding to the TSH-R [TSH-binding inhibitory immunoglobulin (TBII)] or by stimulation [TSH-R stimulating antibody (TSAb)] or inhibition [TSH-R blocking antibody (TSBAb)] of cAMP production in isolated cells.
Objective
We experienced a patient with hypothyroid Graves’ disease (GD) having strong positive TBII, but with almost neutral bioactivities on the TSH-R. The aim of this study is characterization of this apparently paradoxical TBII (sera S).
Design
We first compared the TBII, TSAb and TSBAb activities of sera S with mixtures of stimulating (S-mAb) and blocking monoclonal Ab (B-mAb). Next, we serially measured cAMPs stimulated by various sera in the presence or absence of TSH.
Results
Mixtures of S-mAb and B-mAb did not reproduce the characteristics of sera S. Instead, the sera S had a unique feature which blocked the TSH-stimulated cAMP initially but disappeared the blocking activity thereafter to reach the control level.
Conclusions
We present here the TBIIs with neutral bioactivities found in the patient with autoimmune thyroid disease, which strongly inhibit TSH-binding to the TSH-R but exerts neither TSAb nor TSBAb activity. Differences in the methods to detect TRAb between TBII in vitro and bioassay may cause the discrepancy. Although the sera S may be an extreme example, a variety of TRAb, not only stimulating or blocking but also interfering with TSH-R binding only for a short time, may exist in the sera of GD patients.